Hearing on “Securing the U.S. Drug Supply Chain: Oversight of FDA’s Foreign Inspection Program"
The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce held a hearing on Wednesday, December 10, 2019, at 10:00 a.m. in the John D. Dingell Room, 2123 of the Rayburn House Office Building. The hearing is entitled, “Securing the U.S. Drug Supply Chain: Oversight of FDA’s Foreign Inspection Program."
Memorandum from Chairman Pallone to the Subcommittee on Oversight and Investigations
Opening Statement of Chairman Pallone as prepared for delivery
Opening Statement of Subcommittee Chair DeGette as prepared for delivery
Mary Denigan-Macauley, Ph.D.
Director, Health Care
Government Accountability Office
Janet Woodcock, M.D.
Director, Center for Drug Evaluation and Research
U.S. Food and Drug Administration